ARS Pharmaceuticals (SPRY) Selling, General & Administrative (2020 - 2026)
ARS Pharmaceuticals (SPRY) posted Selling, General & Administrative of $77.58 million for Q2 2026, up 42.8% from $54.31 million a year earlier and up 7.4% from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) Selling, General & Administrative (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at ARS Pharmaceuticals was $284.49 million, up 89.4% year-over-year; for FY2025, it was $230.12 million, up 221.1% from FY2024.
- Annual Selling, General & Administrative has increased for four consecutive years, with a five-year compound annual growth rate of 94.2% (FY2020 to FY2025).
- In prior years, ARS Pharmaceuticals' Selling, General & Administrative was $71.68 million in FY2024 (+51.6%), $47.28 million in FY2023 (+156.2%), $18.46 million in FY2022 (+293.8%) and $4.69 million in FY2021 (-43.8%).
- The Q2 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to Q1 2020.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last eight quarters, with growth averaging 231.0% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q2 2025, with growth of 507.2%; the weakest was Q1 2022, with a decline of 64.8%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $72.2 million (Q1 2026), $59.96 million (Q4 2025) and $74.75 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | ARS Pharmaceuticals | 409.68 Mn | 265.88 Mn | 20.81 Mn | 77.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.58 Mn |
| Mar 31, 2026 | 72.20 Mn |
| Dec 31, 2025 | 59.96 Mn |
| Sep 30, 2025 | 74.75 Mn |
| Jun 30, 2025 | 54.31 Mn |
| Mar 31, 2025 | 41.10 Mn |
| Dec 31, 2024 | 35.49 Mn |
| Sep 30, 2024 | 19.28 Mn |
| Jun 30, 2024 | 8.94 Mn |
| Mar 31, 2024 | 7.96 Mn |
| Dec 31, 2023 | 6.82 Mn |
| Sep 30, 2023 | 14.98 Mn |
| Jun 30, 2023 | 13.31 Mn |
| Mar 31, 2023 | 12.18 Mn |
| Dec 31, 2022 | 10.73 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 2.46 Mn |
| Mar 31, 2022 | 2.34 Mn |
| Dec 31, 2021 | -15.76 Mn |
| Sep 30, 2021 | 7.04 Mn |
API Access
ARS Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();